Thirumalai Chemicals Limited

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ASIANPAINT.BO has a market cap of 2.5T. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ASIANPAINT.BO trades at ₹2,599.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ASIANPAINT.BO's P/E ratio is 64.62. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ASIANPAINT.BO's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ASIANPAINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ASIANPAINT.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ASIANPAINT.NS has a market cap of 2.5T. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ASIANPAINT.NS trades at ₹2,598.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ASIANPAINT.NS's P/E ratio is 64.98. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ASIANPAINT.NS's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ASIANPAINT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ASIANPAINT.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, SOLARINDS.NS has a market cap of 1.6T. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while SOLARINDS.NS trades at ₹18,210.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas SOLARINDS.NS's P/E ratio is 98.55. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to SOLARINDS.NS's ROE of +0.33%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to SOLARINDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check SOLARINDS.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, SOLARINDS.BO has a market cap of 1.6T. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while SOLARINDS.BO trades at ₹18,205.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas SOLARINDS.BO's P/E ratio is 98.62. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to SOLARINDS.BO's ROE of +0.33%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to SOLARINDS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check SOLARINDS.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, PIDILITIND.NS has a market cap of 1.5T. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while PIDILITIND.NS trades at ₹1,455.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas PIDILITIND.NS's P/E ratio is 60.47. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to PIDILITIND.NS's ROE of +0.24%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to PIDILITIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check PIDILITIND.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, PIDILITIND.BO has a market cap of 1.5T. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while PIDILITIND.BO trades at ₹1,455.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas PIDILITIND.BO's P/E ratio is 64.74. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to PIDILITIND.BO's ROE of +0.24%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to PIDILITIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check PIDILITIND.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, SRF.NS has a market cap of 774.6B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while SRF.NS trades at ₹2,613.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas SRF.NS's P/E ratio is 42.17. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to SRF.NS's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to SRF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check SRF.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, SRF.BO has a market cap of 774.6B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while SRF.BO trades at ₹2,613.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas SRF.BO's P/E ratio is 42.19. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to SRF.BO's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to SRF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check SRF.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, LINDEINDIA.NS has a market cap of 618.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while LINDEINDIA.NS trades at ₹7,256.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas LINDEINDIA.NS's P/E ratio is 104.68. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to LINDEINDIA.NS's ROE of +0.16%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to LINDEINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check LINDEINDIA.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, LINDEINDIA.BO has a market cap of 618.5B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while LINDEINDIA.BO trades at ₹7,251.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas LINDEINDIA.BO's P/E ratio is 105.16. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to LINDEINDIA.BO's ROE of +0.16%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to LINDEINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check LINDEINDIA.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, BERGEPAINT.NS has a market cap of 592.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while BERGEPAINT.NS trades at ₹508.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas BERGEPAINT.NS's P/E ratio is 52.69. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to BERGEPAINT.NS's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to BERGEPAINT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check BERGEPAINT.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, BERGEPAINT.BO has a market cap of 592.4B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while BERGEPAINT.BO trades at ₹508.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas BERGEPAINT.BO's P/E ratio is 54.81. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to BERGEPAINT.BO's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to BERGEPAINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check BERGEPAINT.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, FLUOROCHEM.NS has a market cap of 412B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while FLUOROCHEM.NS trades at ₹3,750.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas FLUOROCHEM.NS's P/E ratio is 62.94. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to FLUOROCHEM.NS's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to FLUOROCHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check FLUOROCHEM.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, FLUOROCHEM.BO has a market cap of 412B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while FLUOROCHEM.BO trades at ₹3,750.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas FLUOROCHEM.BO's P/E ratio is 62.90. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to FLUOROCHEM.BO's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to FLUOROCHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check FLUOROCHEM.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, HSCL.BO has a market cap of 293.7B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while HSCL.BO trades at ₹582.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas HSCL.BO's P/E ratio is 38.81. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to HSCL.BO's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to HSCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check HSCL.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, HSCL.NS has a market cap of 293.3B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while HSCL.NS trades at ₹581.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas HSCL.NS's P/E ratio is 38.76. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to HSCL.NS's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to HSCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check HSCL.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ACUTAAS.BO has a market cap of 236.2B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ACUTAAS.BO trades at ₹2,885.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ACUTAAS.BO's P/E ratio is 82.66. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ACUTAAS.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ACUTAAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ACUTAAS.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ACUTAAS.NS has a market cap of 235.8B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ACUTAAS.NS trades at ₹2,880.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ACUTAAS.NS's P/E ratio is 82.40. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ACUTAAS.NS's ROE of +0.24%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ACUTAAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ACUTAAS.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ATUL.NS has a market cap of 205.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ATUL.NS trades at ₹6,992.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ATUL.NS's P/E ratio is 30.33. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ATUL.NS's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ATUL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ATUL.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ATUL.BO has a market cap of 205.6B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ATUL.BO trades at ₹6,984.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ATUL.BO's P/E ratio is 34.61. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ATUL.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ATUL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ATUL.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, KANSAINER.NS has a market cap of 173.5B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while KANSAINER.NS trades at ₹214.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas KANSAINER.NS's P/E ratio is 29.52. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to KANSAINER.NS's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to KANSAINER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check KANSAINER.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, KANSAINER.BO has a market cap of 173.5B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while KANSAINER.BO trades at ₹214.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas KANSAINER.BO's P/E ratio is 29.63. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to KANSAINER.BO's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to KANSAINER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check KANSAINER.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, DCMSHRIRAM.NS has a market cap of 171.2B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while DCMSHRIRAM.NS trades at ₹1,098.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas DCMSHRIRAM.NS's P/E ratio is 20.05. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to DCMSHRIRAM.NS's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to DCMSHRIRAM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check DCMSHRIRAM.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, DCMSHRIRAM.BO has a market cap of 170.7B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while DCMSHRIRAM.BO trades at ₹1,094.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas DCMSHRIRAM.BO's P/E ratio is 20.00. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to DCMSHRIRAM.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to DCMSHRIRAM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check DCMSHRIRAM.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, AARTIIND.BO has a market cap of 168.2B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while AARTIIND.BO trades at ₹464.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas AARTIIND.BO's P/E ratio is 44.57. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to AARTIIND.BO's ROE of +0.07%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to AARTIIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check AARTIIND.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, AARTIIND.NS has a market cap of 168B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while AARTIIND.NS trades at ₹463.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas AARTIIND.NS's P/E ratio is 40.08. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to AARTIIND.NS's ROE of +0.07%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to AARTIIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check AARTIIND.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, BASF.BO has a market cap of 157B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while BASF.BO trades at ₹3,627.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas BASF.BO's P/E ratio is 41.80. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to BASF.BO's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to BASF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check BASF.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, BASF.NS has a market cap of 156.8B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while BASF.NS trades at ₹3,623.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas BASF.NS's P/E ratio is 37.59. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to BASF.NS's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to BASF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check BASF.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ANURAS.BO has a market cap of 156.4B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ANURAS.BO trades at ₹1,373.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ANURAS.BO's P/E ratio is 89.26. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ANURAS.BO's ROE of +0.06%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ANURAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ANURAS.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ANURAS.NS has a market cap of 156.1B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ANURAS.NS trades at ₹1,371.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ANURAS.NS's P/E ratio is 89.17. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ANURAS.NS's ROE of +0.06%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ANURAS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ANURAS.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, AETHER.BO has a market cap of 144.1B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while AETHER.BO trades at ₹1,086.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas AETHER.BO's P/E ratio is 65.71. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to AETHER.BO's ROE of +0.10%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to AETHER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check AETHER.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, AETHER.NS has a market cap of 144.1B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while AETHER.NS trades at ₹1,085.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas AETHER.NS's P/E ratio is 65.59. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to AETHER.NS's ROE of +0.10%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to AETHER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check AETHER.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, FINEORG.NS has a market cap of 140.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while FINEORG.NS trades at ₹4,594.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas FINEORG.NS's P/E ratio is 33.76. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to FINEORG.NS's ROE of +0.17%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to FINEORG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check FINEORG.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, FINEORG.BO has a market cap of 140.7B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while FINEORG.BO trades at ₹4,588.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas FINEORG.BO's P/E ratio is 33.74. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to FINEORG.BO's ROE of +0.17%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to FINEORG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check FINEORG.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, VINATIORGA.BO has a market cap of 137.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while VINATIORGA.BO trades at ₹1,330.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas VINATIORGA.BO's P/E ratio is 31.10. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to VINATIORGA.BO's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to VINATIORGA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check VINATIORGA.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, VINATIORGA.NS has a market cap of 137.8B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while VINATIORGA.NS trades at ₹1,329.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas VINATIORGA.NS's P/E ratio is 31.08. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to VINATIORGA.NS's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to VINATIORGA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check VINATIORGA.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, AKZOINDIA.NS has a market cap of 136B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while AKZOINDIA.NS trades at ₹2,986.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas AKZOINDIA.NS's P/E ratio is 6.95. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to AKZOINDIA.NS's ROE of +1.07%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to AKZOINDIA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check AKZOINDIA.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, AKZOINDIA.BO has a market cap of 136B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while AKZOINDIA.BO trades at ₹2,985.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas AKZOINDIA.BO's P/E ratio is 6.95. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to AKZOINDIA.BO's ROE of +1.07%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to AKZOINDIA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check AKZOINDIA.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, GRWRHITECH.BO has a market cap of 131B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while GRWRHITECH.BO trades at ₹5,637.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas GRWRHITECH.BO's P/E ratio is 38.67. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to GRWRHITECH.BO's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to GRWRHITECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check GRWRHITECH.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, GRWRHITECH.NS has a market cap of 130.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while GRWRHITECH.NS trades at ₹5,635.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas GRWRHITECH.NS's P/E ratio is 38.77. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to GRWRHITECH.NS's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to GRWRHITECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check GRWRHITECH.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, PRIVISCL.BO has a market cap of 124.2B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while PRIVISCL.BO trades at ₹3,178.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas PRIVISCL.BO's P/E ratio is 37.97. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to PRIVISCL.BO's ROE of +0.27%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to PRIVISCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check PRIVISCL.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, PRIVISCL.NS has a market cap of 123.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while PRIVISCL.NS trades at ₹3,173.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas PRIVISCL.NS's P/E ratio is 37.80. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to PRIVISCL.NS's ROE of +0.27%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to PRIVISCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check PRIVISCL.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, JUBLINGREA.BO has a market cap of 116.1B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while JUBLINGREA.BO trades at ₹736.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas JUBLINGREA.BO's P/E ratio is 43.93. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to JUBLINGREA.BO's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to JUBLINGREA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check JUBLINGREA.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, JUBLINGREA.NS has a market cap of 116B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while JUBLINGREA.NS trades at ₹735.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas JUBLINGREA.NS's P/E ratio is 43.83. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to JUBLINGREA.NS's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to JUBLINGREA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check JUBLINGREA.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, PCBL.NS has a market cap of 115.1B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while PCBL.NS trades at ₹292.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas PCBL.NS's P/E ratio is 43.36. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to PCBL.NS's ROE of +0.05%. Regarding short-term risk, TIRUMALCHM.NS is less volatile compared to PCBL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check PCBL.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, PCBL.BO has a market cap of 115B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while PCBL.BO trades at ₹292.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas PCBL.BO's P/E ratio is 43.30. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to PCBL.BO's ROE of +0.05%. Regarding short-term risk, TIRUMALCHM.NS is less volatile compared to PCBL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check PCBL.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, AMIORG.NS has a market cap of 96.3B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while AMIORG.NS trades at ₹1,176.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas AMIORG.NS's P/E ratio is 119.06. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to AMIORG.NS's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to AMIORG.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check AMIORG.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, AMIORG.BO has a market cap of 96.3B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while AMIORG.BO trades at ₹1,176.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas AMIORG.BO's P/E ratio is 118.95. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to AMIORG.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to AMIORG.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check AMIORG.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ALKYLAMINE.BO has a market cap of 90.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ALKYLAMINE.BO trades at ₹1,777.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ALKYLAMINE.BO's P/E ratio is 50.45. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ALKYLAMINE.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ALKYLAMINE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ALKYLAMINE.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ALKYLAMINE.NS has a market cap of 90.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ALKYLAMINE.NS trades at ₹1,776.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ALKYLAMINE.NS's P/E ratio is 50.56. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ALKYLAMINE.NS's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ALKYLAMINE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ALKYLAMINE.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, CLEAN.NS has a market cap of 80.2B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while CLEAN.NS trades at ₹754.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas CLEAN.NS's P/E ratio is 34.93. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to CLEAN.NS's ROE of +0.16%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to CLEAN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check CLEAN.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, CLEAN.BO has a market cap of 80.2B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while CLEAN.BO trades at ₹754.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas CLEAN.BO's P/E ratio is 34.89. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to CLEAN.BO's ROE of +0.16%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to CLEAN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check CLEAN.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, KINGFA.NS has a market cap of 70.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while KINGFA.NS trades at ₹5,231.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas KINGFA.NS's P/E ratio is 40.92. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to KINGFA.NS's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to KINGFA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check KINGFA.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, KINGFA.BO has a market cap of 70.8B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while KINGFA.BO trades at ₹5,227.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas KINGFA.BO's P/E ratio is 40.99. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to KINGFA.BO's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to KINGFA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check KINGFA.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, SUDARSCHEM.BO has a market cap of 68B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while SUDARSCHEM.BO trades at ₹864.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas SUDARSCHEM.BO's P/E ratio is 127.91. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to SUDARSCHEM.BO's ROE of -0.02%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to SUDARSCHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check SUDARSCHEM.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, SUDARSCHEM.NS has a market cap of 67.8B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while SUDARSCHEM.NS trades at ₹862.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas SUDARSCHEM.NS's P/E ratio is -109.43. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to SUDARSCHEM.NS's ROE of -0.02%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to SUDARSCHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check SUDARSCHEM.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, GALAXYSURF.BO has a market cap of 64.7B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while GALAXYSURF.BO trades at ₹1,826.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas GALAXYSURF.BO's P/E ratio is 24.22. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to GALAXYSURF.BO's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to GALAXYSURF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check GALAXYSURF.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, GALAXYSURF.NS has a market cap of 64.7B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while GALAXYSURF.NS trades at ₹1,825.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas GALAXYSURF.NS's P/E ratio is 24.21. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to GALAXYSURF.NS's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to GALAXYSURF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check GALAXYSURF.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, BALAMINES.NS has a market cap of 59.4B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while BALAMINES.NS trades at ₹1,833.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas BALAMINES.NS's P/E ratio is 41.26. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to BALAMINES.NS's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.NS is less volatile compared to BALAMINES.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check BALAMINES.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, BALAMINES.BO has a market cap of 59.2B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while BALAMINES.BO trades at ₹1,827.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas BALAMINES.BO's P/E ratio is 41.03. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to BALAMINES.BO's ROE of +0.09%. Regarding short-term risk, TIRUMALCHM.NS is less volatile compared to BALAMINES.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check BALAMINES.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, INDIGOPNTS.NS has a market cap of 46.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while INDIGOPNTS.NS trades at ₹983.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas INDIGOPNTS.NS's P/E ratio is 32.63. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to INDIGOPNTS.NS's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to INDIGOPNTS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check INDIGOPNTS.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, INDIGOPNTS.BO has a market cap of 46.8B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while INDIGOPNTS.BO trades at ₹982.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas INDIGOPNTS.BO's P/E ratio is 32.53. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to INDIGOPNTS.BO's ROE of +0.14%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to INDIGOPNTS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check INDIGOPNTS.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, NEOGEN.BO has a market cap of 44.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while NEOGEN.BO trades at ₹1,701.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas NEOGEN.BO's P/E ratio is 228.35. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to NEOGEN.BO's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to NEOGEN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check NEOGEN.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, NEOGEN.NS has a market cap of 44.7B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while NEOGEN.NS trades at ₹1,695.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas NEOGEN.NS's P/E ratio is 227.92. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to NEOGEN.NS's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to NEOGEN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check NEOGEN.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, GULFOILLUB.NS has a market cap of 44.6B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while GULFOILLUB.NS trades at ₹901.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas GULFOILLUB.NS's P/E ratio is 12.84. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to GULFOILLUB.NS's ROE of +0.23%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to GULFOILLUB.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check GULFOILLUB.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, GULFOILLUB.BO has a market cap of 44.6B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while GULFOILLUB.BO trades at ₹901.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas GULFOILLUB.BO's P/E ratio is 12.84. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to GULFOILLUB.BO's ROE of +0.23%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to GULFOILLUB.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check GULFOILLUB.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, POCL.NS has a market cap of 44.5B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while POCL.NS trades at ₹1,457.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas POCL.NS's P/E ratio is 39.21. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to POCL.NS's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.NS is less volatile compared to POCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check POCL.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, POCL.BO has a market cap of 44.5B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while POCL.BO trades at ₹1,457.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas POCL.BO's P/E ratio is 38.98. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to POCL.BO's ROE of +0.20%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to POCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check POCL.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, LXCHEM.BO has a market cap of 44B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while LXCHEM.BO trades at ₹158.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas LXCHEM.BO's P/E ratio is 55.30. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to LXCHEM.BO's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to LXCHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check LXCHEM.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, LXCHEM.NS has a market cap of 43.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while LXCHEM.NS trades at ₹158.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas LXCHEM.NS's P/E ratio is 55.22. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to LXCHEM.NS's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to LXCHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check LXCHEM.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, RESPONIND.NS has a market cap of 43.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while RESPONIND.NS trades at ₹164.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas RESPONIND.NS's P/E ratio is 24.37. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to RESPONIND.NS's ROE of +0.13%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to RESPONIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check RESPONIND.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, RESPONIND.BO has a market cap of 43.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while RESPONIND.BO trades at ₹164.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas RESPONIND.BO's P/E ratio is 24.37. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to RESPONIND.BO's ROE of +0.13%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to RESPONIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check RESPONIND.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ADVENZYMES.NS has a market cap of 43.5B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ADVENZYMES.NS trades at ₹388.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ADVENZYMES.NS's P/E ratio is 25.81. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ADVENZYMES.NS's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ADVENZYMES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ADVENZYMES.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ADVENZYMES.BO has a market cap of 43.4B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ADVENZYMES.BO trades at ₹387.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ADVENZYMES.BO's P/E ratio is 25.79. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ADVENZYMES.BO's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ADVENZYMES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ADVENZYMES.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, TANFACIND.BO has a market cap of 42.2B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while TANFACIND.BO trades at ₹2,113.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas TANFACIND.BO's P/E ratio is 59.93. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to TANFACIND.BO's ROE of +0.22%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to TANFACIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check TANFACIND.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, VISHNU.NS has a market cap of 40.4B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while VISHNU.NS trades at ₹599.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas VISHNU.NS's P/E ratio is 29.23. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to VISHNU.NS's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to VISHNU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check VISHNU.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, VISHNU.BO has a market cap of 40.3B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while VISHNU.BO trades at ₹599.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas VISHNU.BO's P/E ratio is 29.19. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to VISHNU.BO's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to VISHNU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check VISHNU.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, JINDALPOLY.BO has a market cap of 30.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while JINDALPOLY.BO trades at ₹705.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas JINDALPOLY.BO's P/E ratio is -23.81. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to JINDALPOLY.BO's ROE of -0.06%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to JINDALPOLY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check JINDALPOLY.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, JINDALPOLY.NS has a market cap of 30.8B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while JINDALPOLY.NS trades at ₹704.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas JINDALPOLY.NS's P/E ratio is -14.52. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to JINDALPOLY.NS's ROE of -0.06%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to JINDALPOLY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check JINDALPOLY.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, PREMEXPLN.BO has a market cap of 29.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while PREMEXPLN.BO trades at ₹556.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas PREMEXPLN.BO's P/E ratio is 69.68. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to PREMEXPLN.BO's ROE of +0.17%. Regarding short-term risk, TIRUMALCHM.NS is less volatile compared to PREMEXPLN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check PREMEXPLN.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, PREMEXPLN.NS has a market cap of 29.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while PREMEXPLN.NS trades at ₹556.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas PREMEXPLN.NS's P/E ratio is 69.73. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to PREMEXPLN.NS's ROE of +0.17%. Regarding short-term risk, TIRUMALCHM.NS is less volatile compared to PREMEXPLN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check PREMEXPLN.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, TATVA.BO has a market cap of 29.1B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while TATVA.BO trades at ₹1,242.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas TATVA.BO's P/E ratio is 88.49. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to TATVA.BO's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to TATVA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check TATVA.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, TATVA.NS has a market cap of 29.1B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while TATVA.NS trades at ₹1,241.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas TATVA.NS's P/E ratio is 88.52. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to TATVA.NS's ROE of +0.04%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to TATVA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check TATVA.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, GRAUWEIL.NS has a market cap of 29B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while GRAUWEIL.NS trades at ₹64.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas GRAUWEIL.NS's P/E ratio is 20.66. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to GRAUWEIL.NS's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to GRAUWEIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check GRAUWEIL.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, GRAUWEIL.BO has a market cap of 29B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while GRAUWEIL.BO trades at ₹63.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas GRAUWEIL.BO's P/E ratio is 20.64. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to GRAUWEIL.BO's ROE of +0.15%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to GRAUWEIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check GRAUWEIL.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, SOTL.NS has a market cap of 28.6B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while SOTL.NS trades at ₹417.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas SOTL.NS's P/E ratio is 15.74. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to SOTL.NS's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to SOTL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check SOTL.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, SOTL.BO has a market cap of 28.6B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while SOTL.BO trades at ₹416.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas SOTL.BO's P/E ratio is 15.72. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to SOTL.BO's ROE of +0.11%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to SOTL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check SOTL.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ROSSARI.BO has a market cap of 28.1B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ROSSARI.BO trades at ₹507.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ROSSARI.BO's P/E ratio is 18.84. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ROSSARI.BO's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ROSSARI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ROSSARI.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, ROSSARI.NS has a market cap of 28.1B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while ROSSARI.NS trades at ₹507.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas ROSSARI.NS's P/E ratio is 18.85. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to ROSSARI.NS's ROE of +0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to ROSSARI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check ROSSARI.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, NOCIL.NS has a market cap of 28B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while NOCIL.NS trades at ₹167.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas NOCIL.NS's P/E ratio is 50.56. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to NOCIL.NS's ROE of +0.03%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to NOCIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check NOCIL.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, NOCIL.BO has a market cap of 28B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while NOCIL.BO trades at ₹167.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas NOCIL.BO's P/E ratio is 44.51. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to NOCIL.BO's ROE of +0.03%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to NOCIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check NOCIL.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, POLYPLEX.NS has a market cap of 27.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while POLYPLEX.NS trades at ₹888.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas POLYPLEX.NS's P/E ratio is 92.37. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to POLYPLEX.NS's ROE of +0.01%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to POLYPLEX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check POLYPLEX.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, POLYPLEX.BO has a market cap of 27.9B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while POLYPLEX.BO trades at ₹888.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas POLYPLEX.BO's P/E ratio is 92.23. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to POLYPLEX.BO's ROE of +0.01%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to POLYPLEX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check POLYPLEX.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, JUBLCPL.BO has a market cap of 26.2B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while JUBLCPL.BO trades at ₹1,726.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas JUBLCPL.BO's P/E ratio is 21.59. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to JUBLCPL.BO's ROE of +0.13%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to JUBLCPL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check JUBLCPL.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, APCOTEXIND.BO has a market cap of 26.1B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while APCOTEXIND.BO trades at ₹504.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas APCOTEXIND.BO's P/E ratio is 31.35. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to APCOTEXIND.BO's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to APCOTEXIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check APCOTEXIND.BO's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, APCOTEXIND.NS has a market cap of 26.1B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while APCOTEXIND.NS trades at ₹503.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas APCOTEXIND.NS's P/E ratio is 25.74. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to APCOTEXIND.NS's ROE of +0.18%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to APCOTEXIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check APCOTEXIND.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, JUBLCPL.NS has a market cap of 26B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while JUBLCPL.NS trades at ₹1,712.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas JUBLCPL.NS's P/E ratio is 21.42. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to JUBLCPL.NS's ROE of +0.33%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to JUBLCPL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check JUBLCPL.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, JUBLINDS.NS has a market cap of 25.6B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while JUBLINDS.NS trades at ₹1,633.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas JUBLINDS.NS's P/E ratio is 72.49. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to JUBLINDS.NS's ROE of +0.13%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to JUBLINDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check JUBLINDS.NS's competition here

TIRUMALCHM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TIRUMALCHM.NS stands at 25.6B. In comparison, TIRUMALCHM.BO has a market cap of 25.5B. Regarding current trading prices, TIRUMALCHM.NS is priced at ₹212.08, while TIRUMALCHM.BO trades at ₹211.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TIRUMALCHM.NS currently has a P/E ratio of -15.05, whereas TIRUMALCHM.BO's P/E ratio is -14.78. In terms of profitability, TIRUMALCHM.NS's ROE is -0.12%, compared to TIRUMALCHM.BO's ROE of -0.12%. Regarding short-term risk, TIRUMALCHM.NS is more volatile compared to TIRUMALCHM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TIRUMALCHM.NS.Check TIRUMALCHM.BO's competition here